Pakistan’s pharmaceutical industry claims that around 40 medical companies will be forced to close due to unaffordable production costs caused by the rupee’s devaluation, import hiccups and spiraling inflation.
Fri. Jul 5th, 2024
Pakistan’s pharmaceutical industry claims that around 40 medical companies will be forced to close due to unaffordable production costs caused by the rupee’s devaluation, import hiccups and spiraling inflation.